Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Paul J. Gaglio"'
Autor:
Rita Jermyn, Eiei Soe, David D’Alessandro, Julia Shin, William Jakobleff, Daniel Schwartz, Milan Kinkhabwala, Paul J. Gaglio
Publikováno v:
Case Reports in Transplantation, Vol 2014 (2014)
Increased hepatic iron load in extrahepatic organs of cirrhotic patients with and without hereditary hemochromatosis portends a poorer long term prognosis after liver transplant. Hepatic as well as nonhepatic iron overload is associated with increase
Externí odkaz:
https://doaj.org/article/500542c060934df3902adf59eafdd5e8
Autor:
Dor Lotan, Ersilia M. DeFilippis, Daniel Oren, Alice Vinogradsky, Gal Rubinstein, Abhishek Mathur, Koji Takeda, May Hua, Paul J. Gaglio, Matthias J. Szabolcs, Gabriel Sayer, Nir Uriel, Alejandro Daniel Iglesias, Farhana Latif
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 33:667-670
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::729a28f092776d3abd4bd96c31a7a6e7
https://doi.org/10.1016/j.numecd.2022.12.022
https://doi.org/10.1016/j.numecd.2022.12.022
Publikováno v:
Clinics in Liver Disease. 24:277-290
Hepatic encephalopathy (HE) is a frequent indication for hospitalization and represents a common manifestation of portal hypertension and decompensated liver disease that contributes to hospital readmissions. Multiple new techniques are being evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb370b0926d293ae6381a811173a080f
https://doi.org/10.1016/j.cld.2020.01.007
https://doi.org/10.1016/j.cld.2020.01.007
Long-Term Management: Modern Measures to Prevent Readmission in Patients with Hepatic Encephalopathy
Publikováno v:
Clinics in liver disease. 24(2)
Hepatic encephalopathy (HE) is a frequent indication for hospitalization and represents a common manifestation of portal hypertension and decompensated liver disease that contributes to hospital readmissions. Multiple new techniques are being evaluat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd5e27fa5c33ae91d34466b608f8c8f1
https://pubmed.ncbi.nlm.nih.gov/32245533
https://pubmed.ncbi.nlm.nih.gov/32245533
Autor:
Paul J. Gaglio, Manhal Izzy, Ghalib Jibara, John F. Reinus, Aws Aljanabi, Mustafa Alani, Allan W. Wolkoff, Zaid Said, Hina Zaidi, Emily R. Giannattasio
Publikováno v:
Journal of Clinical and Experimental Hepatology. 6:100-108
Background Individuals ineligible for interferon-based hepatitis C therapy may have a worse prognosis than patients who have failed or not received treatment. Aims To provide information about the limitations of medical treatment of hepatitis C in re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46b18310299d6a8071c4124468ccbc3
https://doi.org/10.1016/j.jceh.2016.02.006
https://doi.org/10.1016/j.jceh.2016.02.006
Autor:
Kristina R. Chacko, Paul J. Gaglio
Publikováno v:
Clinics in Liver Disease. 19:605-617
This article discusses direct-acting antiviral agents that target hepatitis C virus replication, their mechanism of action, strengths, and weaknesses. In addition, varying strategies using combinations of these agents are discussed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3192c6cb147e6e76b2e900006db07377
https://doi.org/10.1016/j.cld.2015.06.002
https://doi.org/10.1016/j.cld.2015.06.002
Autor:
Sumeet K. Asrani, Raza Malik, Andres Duarte-Rojo, Lee Landeen, Ali Al-Khafaji, Geoffrey W. McCaughan, Anupama T. Duddempudi, Nikunj Shah, Charles S. Landis, David C. Wolf, Marquis Hart, Jan Stange, Robert S. Brown, Steven D. Colquhoun, Rohit Satoskar, Lance L. Stein, Julie A. Thompson, Robert Ashley, Michael B. Millis, Talal Adhami, Rajiv Jalan, Paul J. Gaglio, Andrew Henry, Santiago J Munoz, Shahid Habib, Lewis W. Teperman, Alan Wigg, Parvez S. Mantry, Brian B. Borg, David J. Reich, Shahid M. Malik, Amay Parikh, Linda Sher, Patricia W. Bedard, Ram Subramanian, Alyssa Henry, Natasha Jones, Ahmed Elsharkawy, Tarek Hassanein, Simona Rossi, Heather Patton, Ross MacNicholas, William Frank
Publikováno v:
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 24(3)
Severe alcoholic hepatitis (sAH) is associated with a poor prognosis. There is no proven effective treatment for sAH, which is why early transplantation has been increasingly discussed. Hepatoblastoma-derived C3A cells express anti-inflammatory prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7c7ca67b987f12f92dccee95e2ec68
https://pubmed.ncbi.nlm.nih.gov/29385313
https://pubmed.ncbi.nlm.nih.gov/29385313
Autor:
Maria Coco, Graciella de Boccardo, Andrew Joelson, Soohwan Chun, Maria Ajaimy, Layla Kamal, Enver Akalin, Paul J. Gaglio, Michelle Lubetzky
Publikováno v:
Transplantation. 101(7)
BACKGROUND With the development of all oral, interferon-free directly acting antiviral (DAA) medications, treatment of hepatitis C virus (HCV) infection in renal transplant recipients is possible, but limited data exists on its safety and efficacy. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c9ced41e4571d5b343ee7647a85ffaa
https://pubmed.ncbi.nlm.nih.gov/28009781
https://pubmed.ncbi.nlm.nih.gov/28009781
Autor:
Paul J. Gaglio
Due to the current obesity epidemic, non-alcoholic fatty liver disease (NAFLD) is prevalent in a significant portion of the United States patient population. It is being increasingly recognized that NAFLD affects both adults and children and can prog
Autor:
Meena B. Bansal, Andrea D. Branch, Lawrence U. Liu, John F. Reinus, Valérie Martel-Laferrière, Douglas T. Dieterich, Paul J. Gaglio, Ponni V. Perumalswami, Joseph A. Odin, Jonathan M. Schwartz, Kian Bichoupan, K. Marfo, E. R. Giannattasio, Harmit Kalia, Thomas D. Schiano
Publikováno v:
Alimentary Pharmacology & Therapeutics. 39:209-216
Summary Background Data about adverse events are needed to optimise telaprevir-based therapy in a broad spectrum of patients. Aim To investigate adverse events of telaprevir-based therapy in patients with and without advanced fibrosis or cirrhosis in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cbf6b25aaf37fa2014396e1a0db26d61
https://doi.org/10.1111/apt.12560
https://doi.org/10.1111/apt.12560